Evidence map›Paper›PMID 38162058›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2023

[Sichuan Dark Tea-Based Medicated Dietary Formula Improves Obesity-Induced Renal Lipid Metabolism Disorder in Mice by Remodeling Gut Microbiota and Short-Chain Fatty Acid Metabolism].

Hui Li, Lihan Zhang, Rongshuang Huang, Qian Ren, Fan Guo, Min Shi, Letian Yang, Yang Yu, Liang Ma, Ping Fu

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hui Li( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Lihan Zhang( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Rongshuang Huang( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Qian Ren( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Fan Guo( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Min Shi( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Letian Yang( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Yang Yu( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Liang Ma( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Ping Fu( 610041) Kidney Research Institute, Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the renoprotective effects of a Sichuan dark tea-based medicated dietary formula (alternatively referred to as Qing, or clarity in Chinese) on mice with diet-induced obesity (DIO) and to explore the specific mechanisms involved. Methods: Male C57BL/6 mice were randomly assigned to three groups, a control group, a DIO group, and a Qing treatment group, or the Qing group, with 8 mice in each group. The mice in the control group were given normal maintenance feed and purified water, and the other two groups were fed a high-fat diet for 12 weeks to establish the DIO model. After that, high-fat diet continued in the DIO group, while the Qing group was given Qing at the same time for 12 weeks, during which period the weight of the mice was monitored and recorded every week. The mice were sacrificed after 12 weeks. Serum samples were collected and the levels of triglyceride (TG), total cholesterol (TC), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin were measured to evaluate liver function. In addition, renal lipids were extracted to determine the levels of TG and TC in the kidney and periodic acid-Schiff (PAS) and oil red O stainings were performed to evaluate kidney pathological injury. Western blot was performed to determine the phosphorylated AMPK (pAMPK)/AMPK ratio in the kidney tissue. RT-qPCR and Western blot were used to determine the expression of proteins related to fatty acid oxidation, including acetyl-CoA carboxylase 1 (ACC1), carnitine acyltransferase 1 (CTP1), peroxisome proliferators-activated receptor γ (PPARγ), peroxisome proliferators-activated receptor-1 α (PPAR1α), sterol-regulatory element binding proteins (SREBP-1), and key proteins related to lipid synthesis, including fatty acid synthase (FASN) and stearoyl-coenzyme A desaturase 1 (stearoyl-CoA desaturase) in the kidney tissue. 16SrRNA and metabolomics were applied to analyze the gut microbiota in the intestinal contents and its metabolites. Results: Compared with those of the control group, the levels of liver mass ( Conclusion: Sichuan dark tea-based medicated dietary formula may improve renal lipid metabolism by regulating gut microbiota and the levels of intestinal short-chain fatty acids, thereby protecting obesity-related kidney injury. Isovaleric acid and propionic acid may be the metabolites key to its regulation of gut microbiota.

Indexed as

Gastrointestinal MicrobiomeLipid Metabolism DisordersAMP-Activated Protein KinasesAnimalsDiet, High-FatHemiterpenesLipid MetabolismLiverMaleMiceMice, Inbred C57BLObesityPentanoic AcidsPeroxisome ProliferatorsPPAR gammaPropionatesAMP-Activated Protein KinasesHemiterpenesisovaleric acidPentanoic AcidsPeroxisome ProliferatorsPPAR gammaPropionatespropionic acidSterol Regulatory Element Binding Protein 1TeaTriglyceridesChronic kidney diseaseHigh-fat dietObesityRenal lipid metabolismSichuan dark tea

Identifiers

PMID38162058
PMCPMC10752792
OpenAlexW4390507495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.